Sumatriptan Succinate Injection
Product Images NDC 72603-141

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 72603-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Autoinjector (Autoinjector)

Label for Sumatriptan Injection USP Autoinjector System, 6 mg/0.5 mL strength. Single-dose autoinjector for subcutaneous injection only. Manufactured by Dr. Reddy's Laboratories Limited and labeled by NorthStar Rx LLC. Includes directions about storage and handling. Features barcode and NDC 72603-141-01.*

FDA Label Image

Backcarton (Backcarton)

An illustrated instruction diagram for Sumatriptan Succinate injection, 6 mg/0.5 mL by NorthStar Rx LLC, demonstrating step-by-step how to use the subcutaneous injection pen. Steps include removing the cap, positioning the pen on the skin until a stop point is felt, pressing the blue button to start injection, monitoring the medicine window for full dose delivery, and holding the pen for 5 seconds after injection. Figures A through E show hand positioning and pen usage details.*

FDA Label Image

Carton (Carton)

Packaging label for Sumatriptan Injection USP Autoinjector System, 6 mg/0.5 mL, by NorthStar Rx LLC. The carton contains 2 autoinjectors, each a 0.5 mL prefilled syringe with 6 mg of sumatriptan injection for subcutaneous use. Label includes handling instructions, prescriber information availability, and dosage form details.*

FDA Label Image

Fig (Fig)

A line graph comparing estimated percentage of subjects with relief over time (0 to 25 minutes) between placebo and sumatriptan groups. The sumatriptan group shows a higher percentage of relief over time compared to placebo. The x-axis represents time in minutes, and the y-axis shows estimated percentage of subjects with relief.*

FDA Label Image

Fig1 (Fig1)

Sumatriptan Succinate Injection USP 6 mg/0.5 mL subcutaneous injection device by NorthStar Rx LLC. The image shows a single-use prefilled syringe or autoinjector with a clear barrel, plunger, and a white and blue label. The label includes the product name, strength, and usage route.*

FDA Label Image

Fig10 (Fig10)

An instructional image demonstrating the subcutaneous injection of Sumatriptan Succinate 6 mg/0.5 mL. The image shows a hand holding the auto-injector pen perpendicular to the skin, with a note indicating to wait 5 seconds before lifting the device after injection.*

FDA Label Image

Fig11 (Fig11)

An instructional illustration showing a hand holding a Sumatriptan Succinate injection pen at an angle above the skin, with text instructing to "Take the pen off your skin." This image demonstrates a step in the subcutaneous injection process.*

FDA Label Image

Fig12 (Fig12)

An illustration of a red biohazard waste container with a top opening, labeled with a warning sign featuring a biohazard symbol and the words 'WARNING BIOHAZARD' in black text on an orange background.*

FDA Label Image

Fig2 (Fig2)

An instructional diagram of a Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection pen showing labeled parts including the cap, medicine window, and button. Text explains removing the cap to activate the pen, using the window to confirm the liquid is clear, and pressing the button firmly to start the injection.*

FDA Label Image

Fig3 (Fig3)

An instructional illustration showing the injection sites for Sumatriptan Succinate injection. The image depicts a person self-administering the subcutaneous injection to two possible areas: the thigh and the arm. The injection device has a blue cap and label, held firmly against the skin in both positions.*

FDA Label Image

Fig4 (Fig4)

An instructional diagram showing two stages of a Sumatriptan Succinate subcutaneous injection. The first image labeled 'Before Injection' shows the clear liquid medication inside the syringe. The second image labeled 'After Injection' shows the blue plunger rod filling the window post-injection, illustrating the completed dose delivery.*

FDA Label Image

Fig5 (Fig5)

An instructional illustration showing a person holding a Sumatriptan Succinate subcutaneous injection device and pulling the cap straight off to remove it. The image includes directional arrows and the label 'Figure D' below.*

FDA Label Image

Fig6 (Fig6)

An instructional illustration showing two views of a beige injection device component for Sumatriptan Succinate injection. The top image displays the correct assembly or positioning with a green check mark, while the bottom image shows an incorrect assembly with a red X mark, labeled as Figure E.*

FDA Label Image

Fig7 (Fig7)

An instructional illustration demonstrating the correct technique for subcutaneous injection of Sumatriptan Succinate. It shows a hand holding the syringe at a 90-degree angle to the skin, pressing down against the skin to unlock the device. Directional arrows and text highlight the steps for proper administration.*

FDA Label Image

Fig8 (Fig8)

An instructional illustration showing the administration of Sumatriptan Succinate injection subcutaneously. A hand is pressing down on the injector device over the skin, with the label 'Click' and arrow indicating to press the device for activation.*

FDA Label Image

Fig9 (Fig9)

An instructional illustration showing a subcutaneous injection being administered with a Sumatriptan Succinate injection device. The image highlights that after injection, the blue plunger moves downward to completely fill the medicine window.*

FDA Label Image

Stru (Stru)

Chemical structure diagram of sumatriptan succinate, showing its indole core with substituents and succinate salt moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.